drugset / Trial / NCT00202553

S90652 in Paediatric Hypertension

NCT00202553

Phase 2 Completed 50 enrolled Servier
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of the study is to assess the acceptability, safety and pharmacokinetics and effects on blood pressure of a paediatric formulation of perindopril given in hypertensive children

Timeline

Start
2003-07
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Perindopril Small molecule 0.025 mg/kg
Subject Perindopril Small molecule 0.135 mg/kg

Indications